From: Exit Staff
Pfizer Still in Discussions with Kosovo

Pfizer/BioNtech is still in discussions with the outgoing Government of Kosovo for the supply of coronavirus vaccines.

This has been confirmed for Radio Free Europe, by the company Pfizer.

“We are still in discussions with the Government in Kosovo to ensure access to the vaccine. The talks are secret and we do not have any information to announce at the moment,” Ursa Lakner, a senior Pfizer official told RFE.

The Ministry of Health in Kosovo, in early January, had announced that it had received confirmation from the American company Pfizer, for the provision of 535,000 vaccines against coronavirus.

On 19 February, the Ministry of Health did not announce an exact date when the Pfizer / BioNTech and AstraZeneca vaccines could arrive in Kosovo, although the acting Minister of Health, Armend Zemaj had announced that their arrival could be expected in February.

Kosovo is expected to receive the AstraZeneca and Oxford vaccine against coronavirus free of charge through the World Health Organization’s program, COVAX which aims to distribute vaccines to poor countries.

Kosovo expects to receive from COVAX about 100,800 doses of this vaccine.

Kosovo reported 340 new cases infected with coronavirus on Friday. There are currently 6,737 active cases in the country.